CHARMM Force-Field Parameters for Morphine, Heroin, and Oliceridine, and Conformational Dynamics of Opioid Drugs

被引:12
作者
Giannos, Thomas [1 ]
Lesnik, Samo [2 ]
Bren, Urban [2 ,3 ]
Hodoscek, Milan [4 ]
Domratcheva, Tatiana [5 ,6 ]
Bondar, Ana-Nicoleta [1 ,7 ,8 ,9 ]
机构
[1] Free Univ Berlin, Dept Phys, Theoret Mol Biophys Grp, D-14195 Berlin, Germany
[2] Univ Maribor, Lab Phys Chem & Chem Thermodynam, Fac Chem & Chem Engn, SI-2000 Maribor, Slovenia
[3] Univ Primorska, Fac Math Nat Sci & Informat Technol, SI-6000 Koper, Slovenia
[4] Natl Inst Chem Slovenia, Theory Dept, SI-1001 Ljubljana, Slovenia
[5] Lomonosov Moscow State Univ, Dept Chem, Moscow 119991, Russia
[6] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany
[7] Univ Bucharest, Fac Phys, Magurele 077125, Romania
[8] Forschungszentrum Julich, Inst Neurosci & Med, Computat Biomed, D-52425 Julich, Germany
[9] Forschungszentrum Julich, Inst Adv Simulat IAS 5 INM 9, Computat Biomed, D-52425 Julich, Germany
关键词
RECEPTOR; AUTOMATION; FENTANYL; PROGRAM;
D O I
10.1021/acs.jcim.1c00667
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Opioid drug binding to specialized G protein-coupled receptors (GPCRs) can lead to analgesia upon activation via downstream G(1) protein signaling and to severe side effects via activation of the beta-arrestin signaling pathway. Knowledge of how different opioid drugs interact with receptors is essential, as it can inform and guide the design of safer therapeutics. We performed quantum and classical mechanical computations to explore the potential energy landscape of four opioid drugs: morphine and its derivatives heroin and fentanyl and for the unrelated oliceridine. From potential energy profiles for bond twists and from interactions between opioids and water, we derived a set of force-field parameters that allow a good description of structural properties and intermolecular interactions of the opioids. Potential of mean force profiles computed from molecular dynamics simulations indicate that fentanyl and oliceridine have complex energy landscapes with relatively small energy penalties, suggesting that interactions with the receptor could select different binding poses of the drugs.
引用
收藏
页码:3964 / 3977
页数:14
相关论文
共 33 条
[1]  
Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105
[2]   Protein-water hydrogen-bond networks of G protein-coupled receptors: Graph-based analyses of static structures and molecular dynamics [J].
Bertalan, Eva ;
Lesnik, Samo ;
Bren, Urban ;
Bondar, Ana-Nicoleta .
JOURNAL OF STRUCTURAL BIOLOGY, 2020, 212 (03)
[3]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[4]   Novel Opioid Analgesics and Side Effects [J].
Del Vecchio, Giovanna ;
Spahn, Viola ;
Stein, Christoph .
ACS CHEMICAL NEUROSCIENCE, 2017, 8 (08) :1638-1640
[5]   A diacetylmorphine polymorph [J].
Deschamps, JR ;
George, C ;
FlippenAnderson, JL .
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1996, 52 :698-700
[6]   A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphines [J].
DeWire, Scott M. ;
Yamashita, Dennis S. ;
Rominger, David H. ;
Liu, Guodong ;
Cowan, Conrad L. ;
Graczyk, Thomas M. ;
Chen, Xiao-Tao ;
Pitis, Philip M. ;
Gotchev, Dimitar ;
Yuan, Catherine ;
Koblish, Michael ;
Lark, Michael W. ;
Violin, Jonathan D. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 344 (03) :708-717
[7]   Steric interactions and the activity of fentanyl analogs at the μ-opioid receptor [J].
Dosen-Micovic, L ;
Ivanovic, M ;
Micovic, V .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (09) :2887-2895
[8]  
Frisch M.J., 2009, GAUSSION 09 REVISION
[9]   Stable polymorph of morphine [J].
Gelbrich, Thomas ;
Braun, Doris E. ;
Griesser, Ulrich J. .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 :O2-+
[10]   Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists [J].
Gillis, Alexander ;
Gondin, Arisbel B. ;
Kliewer, Andrea ;
Sanchez, Julie ;
Lim, Herman D. ;
Alamein, Claudia ;
Manandhar, Preeti ;
Santiago, Marina ;
Fritzwanker, Sebastian ;
Schmidel, Frank ;
Katte, Timothy A. ;
Reekie, Tristan ;
Grimsey, Natasha L. ;
Kassiou, Michael ;
Kellam, Barrie ;
Krasel, Cornelius ;
Halls, Michelle L. ;
Connor, Mark ;
Lane, J. Robert ;
Schulz, Stefan ;
Christie, Macdonald J. ;
Canals, Meritxell .
SCIENCE SIGNALING, 2020, 13 (625)